BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12024025)

  • 1. Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking.
    Deroo BJ; Rentsch C; Sampath S; Young J; DeFranco DB; Archer TK
    Mol Cell Biol; 2002 Jun; 22(12):4113-23. PubMed ID: 12024025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and dynamic properties of a glucocorticoid receptor-induced chromatin transition.
    Fletcher TM; Ryu BW; Baumann CT; Warren BS; Fragoso G; John S; Hager GL
    Mol Cell Biol; 2000 Sep; 20(17):6466-75. PubMed ID: 10938123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein beta interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus.
    Kino T; Tiulpakov A; Ichijo T; Chheng L; Kozasa T; Chrousos GP
    J Cell Biol; 2005 Jun; 169(6):885-96. PubMed ID: 15955845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TBP binding-induced folding of the glucocorticoid receptor AF1 domain facilitates its interaction with steroid receptor coactivator-1.
    Khan SH; Ling J; Kumar R
    PLoS One; 2011; 6(7):e21939. PubMed ID: 21760925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular chaperones function as steroid receptor nuclear mobility factors.
    Elbi C; Walker DA; Romero G; Sullivan WP; Toft DO; Hager GL; DeFranco DB
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):2876-81. PubMed ID: 14978266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear receptors and chromatin remodeling machinery.
    Trotter KW; Archer TK
    Mol Cell Endocrinol; 2007 Feb; 265-266():162-7. PubMed ID: 17240047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment and dynamics of proteasome association with rhTRIM5α cytoplasmic complexes during HIV-1 infection.
    Danielson CM; Cianci GC; Hope TJ
    Traffic; 2012 Sep; 13(9):1206-17. PubMed ID: 22624877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMOylation regulates the protein network and chromatin accessibility at glucocorticoid receptor-binding sites.
    Paakinaho V; Lempiäinen JK; Sigismondo G; Niskanen EA; Malinen M; Jääskeläinen T; Varjosalo M; Krijgsveld J; Palvimo JJ
    Nucleic Acids Res; 2021 Feb; 49(4):1951-1971. PubMed ID: 33524141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the Direction of Nucleocytoplasmic Transport of Glucocorticoid Receptor (GR) in Live Cells Using Two-Foci Cross-Correlation in Massively Parallel Fluorescence Correlation Spectroscopy (mpFCS).
    Nikolić SN; Oasa S; Krmpot AJ; Terenius L; Belić MR; Rigler R; Vukojević V
    Anal Chem; 2023 Oct; 95(41):15171-15179. PubMed ID: 37782779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the molecular interactions involved in phase separation of glucocorticoid receptor.
    Stortz M; Pecci A; Presman DM; Levi V
    BMC Biol; 2020 Jun; 18(1):59. PubMed ID: 32487073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming the chromatin landscape: interplay of the estrogen and glucocorticoid receptors at the genomic level.
    Miranda TB; Voss TC; Sung MH; Baek S; John S; Hawkins M; Grøntved L; Schiltz RL; Hager GL
    Cancer Res; 2013 Aug; 73(16):5130-9. PubMed ID: 23803465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of chromatin structure on PR signaling: transition from local to global analysis.
    Grøntved L; Hager GL
    Mol Cell Endocrinol; 2012 Jun; 357(1-2):30-6. PubMed ID: 21958695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome Inhibition Reprograms Chromatin Landscape in Breast Cancer.
    Kinyamu HK; Bennett BD; Ward JM; Archer TK
    Cancer Res Commun; 2024 Apr; 4(4):1082-1099. PubMed ID: 38625038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid receptor signaling: intricacies and therapeutic opportunities.
    Clarisse D; Van Moortel L; Van Leene C; Gevaert K; De Bosscher K
    Trends Biochem Sci; 2024 May; 49(5):431-444. PubMed ID: 38429217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex dynamics of transcription regulation.
    Stavreva DA; Varticovski L; Hager GL
    Biochim Biophys Acta; 2012 Jul; 1819(7):657-66. PubMed ID: 22484099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome inhibition reprograms chromatin landscape in breast cancer.
    Kinyamu HK; Bennett BD; Ward JM; Archer T
    bioRxiv; 2023 Oct; ():. PubMed ID: 37904968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylation-induced proteasomal degradation of the activated glucocorticoid receptor limits hormonal signaling.
    Iyer-Bierhoff A; Wieczorek M; Peter SM; Ward D; Bens M; Vettorazzi S; Guehrs KH; Tuckermann JP; Heinzel T
    iScience; 2024 Feb; 27(2):108943. PubMed ID: 38333702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia.
    Borin C; Pieters T; Serafin V; Ntziachristos P
    Hemasphere; 2023 Jul; 7(7):e916. PubMed ID: 37359189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA binding by the glucocorticoid receptor attenuates dexamethasone-induced gene activation.
    Lammer NC; Ashraf HM; Ugay DA; Spencer SL; Allen MA; Batey RT; Wuttke DS
    Sci Rep; 2023 Jun; 13(1):9385. PubMed ID: 37296231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased HIV-1 infection in PBMCs treated in vitro with menstrual cycle phase hormones or medroxyprogesterone acetate likely occurs via different mechanisms.
    Bick AJ; Avenant C; Tomasicchio M; van der Spuy Z; Hapgood JP
    Am J Reprod Immunol; 2022 Dec; 88(6):e13643. PubMed ID: 36302121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.